市場調查報告書
商品編碼
1559457
顱顏面固定 (CMF) 裝置 - 市場回顧、競爭格局、市場預測 (2030)Cranio Maxillofacial Fixation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
2023年全球顱顏固定 (CMF) 設備市場規模預估為17.6億美元,預計2030年將達到23.6億美元,估計2024年至2030年將成長。為5.05%。由於機動車事故和運動導致的腦外傷發病率高、上顎骨骨折的發生率很高、臉部創傷病例的複雜性不斷增加,以及定制植入物的3D 列印等先進技術的集成,預計到2024年該市場將成長。
顱顏面固定 (CMF) 設備的市場動態
根據國際腦損傷協會 (2024年) 的資料,歐盟 (EU) 每年約有 100萬人因腦損傷住院。其中,機車事故佔創傷性腦損傷 (TBI) 的50%。此外,與運動相關的腦損傷也對這一數字做出了重大貢獻,估計每年有 30萬人受傷。冬季運動,特別是滑雪和滑冰,與大約20,000 例腦損傷有關。因此,機動車輛事故和體育相關活動造成的腦損傷的高發生率增加了對有效治療解決方案的需求,增加了對顱顏固定 (CMF) 設備來解決這些損傷的需求。
根據美國國立衛生研究院 (2023) 的資料,運動傷害在上顎骨骨折中佔很大一部分,範圍從 6%到 33%。紐西蘭一項針對 25,000名臉部骨折患者的研究發現,63.5%的患者出現中顏面骨折,而只有 3.3%的患者出現上顏面骨折。根據2019年的資料,對 93名臉部外傷患者進行回顧,56.9%的病例眶下孔受到影響,86%的病例觀察到眶底移位。因此,運動傷害導致的上顎骨骨折的流行、顏面中部的嚴重受累以及眶下孔和眼眶底移位的高發生率強烈表明了對顱顏面固定 (CMF) 裝置的需求。
此外,用於開發定制患者專用植入物的3D 列印等先進技術的整合以及目標人群的高度偏好也將推動顱頜面固定 (CMF) 設備市場的成長。例如,2021年7月,Lucid Implants 在印度宣布,將利用先進的3D 列印技術和虛擬手術規劃,根據患者獨特的臉部解剖結構製造基於聚醚醚酮 (PEEK) 的客製化植入物,這是第一家這樣做的公司。
因此,在2024年至2030年的預測期內,上述所有因素預計將相互作用,推動顱顏固定 (CMF) 設備市場的發展。
然而,植入物的機械故障,包括彎曲、鬆動和斷裂,以及由於壓力和血腫導致的暫時或慢性神經損傷,可能會抑制顱顏面固定 (CMF) 設備市場的成長。顱顏面固定 (CMF) 設備細分市場分析
在顱顏面固定 (CMF) 設備市場的應用領域,神經外科類別預計將在2023年佔據最大的市場收入佔有率。這一類別的快速成長可歸因於神經系統疾病和創傷性腦損傷的日益流行,這些疾病和腦外傷經常需要複雜的顱骨修復和重建。神經外科手術通常包括對顱顏結構的複雜且關鍵的干預,需要使用固定裝置來確保穩定和準確的結果。
神經外科技術和技術的進步,例如增強成像和微創方法,促進該細分市場的成長。這些設備在為接受神經外科手術的患者提供結構支撐和促進最佳復健方面發揮著重要作用。隨著神經外科的不斷發展和擴展,對高品質 CMF 固定解決方案的依賴預計將進一步增加其收入佔有率。
因此,由於上述所有因素,預計神經外科類別將在2024-2030年預測期內表現出可觀的成長,並最終促進整個顱顏固定 (CMF) 設備市場的成長。本報告研究和分析了全球顱顎面固定 (CMF) 設備市場,提供了每個地區的市場規模和預測、過去三年的產品/技術發展以及每個細分市場的業績和前景等資訊. .
Cranio Maxillofacial Fixation (CMF) Devices Market by Product Type (CMF Plate And Screw Fixation Devices, Cranial Flap Fixation Devices, CMF Distraction Devices, Temporomandibular Joint Replacement Devices, and Bone Graft Substitute), Material (Metals & Alloys, Bioabsorbable, Ceramics, and Others), Application (Neurosurgery, Orthognathic Surgery, Plastic Surgery, and Others), End-User (Hospitals, Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the increasing incidence of traumatic brain injuries, facial fractures, and the rising research and product development activities across the globe
The cranio maxillofacial fixation devices market was valued at USD 1.76 billion in 2023, growing at a CAGR of 5.05% during the forecast period from 2024 to 2030 to reach USD 2.36 billion by 2030. The cranio maxillofacial fixation devices market is experiencing significant growth owing to the high incidence of traumatic brain injuries from motor vehicle accidents, and sports, the considerable prevalence of maxillary fractures, and the increasing complexity of facial trauma cases, the integration of advanced technologies like 3D printing for customized implants, among others which is expected to drive the cranio maxillofacial fixation devices market during the forecast period from 2024 to 2030.
Cranio Maxillofacial Fixation (CMF) Devices Market Dynamics:
According to International Brain Injury Association (2024), brain injuries result in approximately one million hospital admissions annually within the European Union. Among these, motor vehicle crashes are responsible for 50% of traumatic brain injuries (TBIs). Additionally, sports-related brain injuries contribute significantly to this figure, with an estimated 300,000 injuries occurring each year. Winter sports, particularly skiing and ice-skating, are linked to around 20,000 of these brain injuries. Thus high incidence of brain injuries from motor vehicle crashes and sports-related activities underscores a growing need for effective treatment solutions, highlighting the demand for cranio maxillofacial fixation (CMF) devices to address these injuries.
According to data from the National Institute of Health (2023), sporting injuries account for a significant portion of maxillary fractures, ranging from 6% to 33%. A study in New Zealand of 25,000 patients with facial fractures found that a substantial portion involved the midface, at 63.5%, while only 3.3% involved the upper third of the face. A review of 93 patients with facial trauma revealed that the infraorbital foramen was affected in 56.9% of cases, and displacement of the orbital floor was present in 86% of cases based on data from 2019. Thus, the prevalence of maxillary fractures due to sporting injuries, the significant involvement of the midface, and the high rates of infraorbital foramen and orbital floor displacement highlight the demand for Cranio Maxillofacial Fixation (CMF) devices.
Furthermore, integrating advanced technology such as 3-D printing for developing customized and patient-specific implants and their high preference among the target population is also projected to grow the cranio maxillofacial fixation devices market. For instance, in July 2021, Lucid Implants became the first Indian company to produce Polyether ether ketone (PEEK) based customized implants keeping patients' unique facial anatomy in mind with advanced 3D printing technologies and virtual surgical planning.
Hence, the interplay of all the above mentioned factors are expected to drive the market of cranio maxillofacial fixation (CMF) devices market during the given forecast period from 2024 to 2030.
However, mechanical failure of the implant, including bending, loosening or breakage and temporary or chronic neural damage resulting from pressure or hematomata may restrain the growth of the cranio maxillofacial fixation (CMF) devices market.
Cranio Maxillofacial Fixation (CMF) Devices Market Segment Analysis:
Cranio Maxillofacial Fixation (CMF) Devices Market by Product Type (CMF Plate And Screw Fixation Devices, Cranial Flap Fixation Devices, CMF Distraction Devices, Temporomandibular Joint Replacement Devices, and Bone Graft Substitute), Material (Metals & Alloys, Bioabsorbable, Ceramics, and Others), Application (Neurosurgery, Orthognathic Surgery, Plastic Surgery, and Others), End-User (Hospitals, Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the application segment of cranio maxillofacial fixation (CMF) device market, the neurosurgery category is predicted to account for the largest market revenue share in 2023. The rapid growth of this category can be attributed due the increasing prevalence of neurological disorders and traumatic brain injuries, which frequently require complex cranial repairs and reconstructions. Neurosurgical procedures often involve intricate and critical interventions on the craniofacial structure, necessitating the use of fixation devices to ensure stable and precise outcomes.
The advancements in neurosurgical techniques and technology, including enhanced imaging and minimally invasive approaches, have contributed to the growth of this segment. These devices play a crucial role in providing structural support and facilitating optimal recovery in neurosurgical patients. As neurosurgery continues to evolve and expand, the reliance on high-quality CMF fixation solutions is expected to further bolster its revenue share.
Therefore, due to all the aforementioned factors, the neurosurgery category is likely to witness considerable growth, eventually contributing to growth of the overall cranio maxillofacial fixation (CMF) device market during the forecast period from 2024 to 2030.
North America is expected to dominate the overall cranio maxillofacial fixation (CMF) device market:
Among all the regions, North America is expected to amass the largest share of the cranio maxillofacial fixation (CMF) devices market. This can be ascribed to the rising incidence of facial cosmetic procedures and traumatic brain injuries, advancements in product development & regulatory approvals, and the significant contributions of key market players in the region. The combination of these factors is expected to drive the continued expansion and innovation in the cranio maxillofacial fixation (CMF) device market from 2024 to 2030.
As per data from the American Society of Plastic Surgeons for 2024, there were 1,575,244 facial cosmetic surgery procedures performed in the United States in 2023. This represents a notable increase from the 1,498,361 procedures conducted in 2022, reflecting a growth rate of approximately 5%. This upward trend highlights the growing demand for facial cosmetic procedures, underscoring the expanding market of cranio maxillofacial fixation (CMF) device.
According to the data provided by the Centre for Disease Control and Prevention (2024), in 2021, there were more than 586 traumatic brain injury-related hospitalizations per day in the US. Traumatic brain injuries, caused by head trauma from accidents, falls, or sports injuries, require prompt and accurate diagnosis to assess the extent of brain damage and guide treatment decisions. These conditions often lead to fractures that require surgical intervention and stabilization to ensure proper healing.
Increasing product developmental activities by the regulatory body like product clearances in the region also pushes forward the revenue share of these devices. For instance, in December 2023, RevBio, Inc. announced approval from the U.S. Food and Drug Administration to initiate a pilot clinical trial involving 20 patients. This trial will evaluate the safety and efficacy of TETRANITE, the company's innovative bone adhesive biomaterial, for the immediate stabilization and fixation of cranial flaps following craniotomy procedures related to brain surgery.
The presence of key market players in the region is significantly bolstering the market for Cranio Maxillofacial Fixation (CMF) devices. Major companies like Stryker, Zimmer Biomet, and Medtronic have established strong footholds in the region, driving innovation and market growth. For example Zimmer Biomet's commitment to developing cutting-edge CMF devices, such as their comprehensive range of fixation plates and screws, has further strengthened their market position. The extensive research and development activities, combined with a robust distribution network, enable these players to deliver high-quality, technologically advanced products to a wide end-user base.
Thus, all the factors mentioned above promote a conducive environment for the cranio maxillofacial fixation (CMF) devices market during the forecast period from 2024 to 2030.
Cranio Maxillofacial Fixation (CMF) Devices Market key players:
Some of the key market players operating in the cranio maxillofacial fixation devices market include Zimmer Biomet, Stryker Corporation, Medtronic, Johnson & Johnson Services, Inc, Advin Health Care, LUCID Implants, Auxein Medical, KLS Martin Group, Medartis AG, Integra LifeSciences, Aesculap, Inc, OsteoMed, Inion, JEIL MEDICAL CORPORATION, and others.
Recent Developmental Activities in the Cranio Maxillofacial Fixation (CMF) Devices Market:
Key Takeaways from the Cranio Maxillofacial Fixation (CMF) Devices Market Report Study
Target audience who can be benefited from this Cranio Maxillofacial Fixation (CMF) Devices Market Report Study
Frequently Asked Questions for the Cranio Maxillofacial Fixation (CMF) Devices Market:
Cranio maxillofacial fixation (CMF) devices are used to rectify the facial deformity or skull fracture to restore proper function. The CMF devices include plate and screw systems, distractors, bone grafts, and others.
The cranio maxillofacial fixation devices market was valued at USD 1.76 billion in 2023, growing at a CAGR of 5.05% during the forecast period from 2024 to 2030 to reach USD 2.36 billion by 2030.
The cranio maxillofacial fixation devices market is experiencing significant growth owing to the high incidence of traumatic brain injuries from motor vehicle accidents and sports, the significant prevalence of maxillary fractures, and the increasing complexity of facial trauma cases, the integration of advanced technologies like 3D printing for customized implants further supports this growth, and among others which is expected to drive the cranio maxillofacial fixation devices market during the forecast period from 2024 to 2030.
Some of the key market players operating in the cranio maxillofacial fixation devices market include Zimmer Biomet, Stryker Corporation, Medtronic, Johnson & Johnson Services, Inc, Advin Health Care, LUCID Implants, Auxein Medical, KLS Martin Group, Medartis AG, Integra LifeSciences, Aesculap, Inc, OsteoMed, Inion, JEIL MEDICAL CORPORATION, and others.
Among all the regions, North America is estimated to hold a significant revenue share in the cranio maxillofacial fixation devices market. This can be ascribed to the rising incidence of facial cosmetic procedures and traumatic brain injuries, advancements in product development & regulatory approvals, and the significant contributions of key market players in the region. The combination of these factors is expected to drive the continued expansion and innovation in the cranio maxillofacial fixation (CMF) device market from 2024 to 2030.